# B-1a cells mitigate radiation injury by protecting intestinal barrier integrity

**Authors:** Tomoki Abe, Atsushi Murao, Satoshi Yamaga, Ping Wang, Monowar Aziz

PMC · DOI: 10.3389/fimmu.2026.1761007 · Frontiers in Immunology · 2026-02-04

## TL;DR

B-1a cells help reduce radiation damage to the gut by maintaining the intestinal barrier and increasing TGF-β production.

## Contribution

This study shows B-1a cells mitigate radiation injury through TGF-β and intestinal barrier protection.

## Key findings

- Irradiation reduces B-1a cell numbers and increases gut damage and permeability.
- Transferring B-1a cells improves gut health and increases TGF-β levels.
- TGF-β-positive B-1a cells in the peritoneal cavity contribute to tissue repair.

## Abstract

Ionizing radiation causes severe gastrointestinal injury. B-1a cells, predominantly located in the peritoneal cavity (PerC), play a critical role in maintaining tissue homeostasis through the secretion of cytokines and natural antibodies. We aim to investigate the status of B-1a cells after irradiation, and their role in ameliorating radiation-induced intestinal injury.

C57BL/6 mice were exposed to 12-Gy partial body irradiation (PBI) and B-1a cells in the PerC, spleen and bone marrow were determined by flow cytometry. After 24 hours of PBI, 5×105 B-1a cells were intraperitoneally administered in additional animals. Gut histology, intestinal barrier function, tissue injury markers, and TGF-β levels in PerC and gut tissue were assessed.

Irradiation induced apoptosis in B-1a cells, resulting in depletion of B-1a cell numbers. Irradiation increased apoptotic cells in the crypts, decreased tight junction protein expression, and enhanced intestinal permeability. Adoptive transfer of B-1a cells significantly ameliorated these changes. The number of TGF-β-positive B-1a cells in PerC increased after B-1a cell transfer, accompanied by elevated TGF-β levels in both PerC and gut tissue.

We demonstrated that B-1a cell numbers are significantly decreased following PBI and that B-1a cell treatment alleviates radiation-induced intestinal injury possibly via the increase in TGF-β production.

## Linked entities

- **Proteins:** TGFB1 (transforming growth factor beta 1)

## Full-text entities

- **Genes:** Fcer2a (Fc receptor, IgE, low affinity II, alpha polypeptide) [NCBI Gene 14128] {aka CD23, Fce2, Fcer2, Ly-42}, Tjp1 (tight junction protein 1) [NCBI Gene 21872] {aka ZO1}, Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}, Cat (catalase) [NCBI Gene 12359] {aka 2210418N07, Cas-1, Cas1, Cs-1}, Apc (APC, WNT signaling pathway regulator) [NCBI Gene 11789] {aka CC1, Min, mAPC}, elap (eye lens aplasia) [NCBI Gene 13708] {aka lap}, Anxa5 (annexin A5) [NCBI Gene 11747] {aka Anx5, CPB-I}, Lgr5 (leucine rich repeat containing G protein coupled receptor 5) [NCBI Gene 14160] {aka FEX, Gpr49}, Foxp3 (forkhead box P3) [NCBI Gene 20371] {aka JM2, scurfin, sf}, Ptprc (protein tyrosine phosphatase receptor type C) [NCBI Gene 19264] {aka B220, CD45R, Cd45, L-CA, Ly-5, Lyt-4}, Cd5 (CD5 antigen) [NCBI Gene 12507] {aka Ly-1, Ly-12, Ly-A, Lyt-1}, Slc17a5 (solute carrier family 17 (anion/sugar transporter), member 5) [NCBI Gene 235504] {aka 4631416G20Rik, 4732491M05, AST, ISSD, NSD, SD}, Tgfb1 (transforming growth factor, beta 1) [NCBI Gene 21803] {aka TGF-beta1, TGFbeta1, Tgfb, Tgfb-1}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Il10 (interleukin 10) [NCBI Gene 16153] {aka CSIF, If2a, Il-10}, Cd19 (CD19 antigen) [NCBI Gene 12478], Ppargc1b (peroxisome proliferative activated receptor, gamma, coactivator 1 beta) [NCBI Gene 170826] {aka 4631412G21Rik, PGC-1beta, PGC-1beta/ERRL1, PPARGC-1-beta, Perc}, Il22 (interleukin 22) [NCBI Gene 50929] {aka IL-22, IL-22a, ILTIFa, If2b1, Iltif}, Csf2 (colony stimulating factor 2 (granulocyte-macrophage)) [NCBI Gene 12981] {aka CSF, Csfgm, GMCSF, Gm-CSf, MGI-IGM}
- **Diseases:** bleeding (MESH:D006470), injury to other organs (MESH:D009102), ischemia (MESH:D007511), fibrosis (MESH:D005355), chronic inflammation (MESH:D007249), cancer (MESH:D009369), ischemic (MESH:D002545), parasitic infections (MESH:D010272), radiation injury (MESH:D011832), sepsis (MESH:D018805), Tissue injury (MESH:D017695), intestinal damage (MESH:D007410), reperfusion injury (MESH:D015427), weight loss (MESH:D015431), cytotoxic (MESH:D064420), immune dysfunction (MESH:D007154), gastrointestinal injury (MESH:D005767), infection (MESH:D007239)
- **Chemicals:** FITC-dextran (MESH:C015219), DTT (MESH:D004229), PI (MESH:D010716), paraffin (MESH:D010232), streptomycin (MESH:D013307), EDTA (MESH:D004492), lactate (MESH:D019344), Cy5.5 (MESH:C098793), FITC (MESH:D016650), CO2 (MESH:D002245), citrate (MESH:D019343), reactive oxygen species (MESH:D017382), DAPI (MESH:C007293), Formalin (MESH:D005557), PBS (MESH:D007854), eosin (MESH:D004801), Alexa Fluor 647 (MESH:C569686), hematoxylin (MESH:D006416), penicillin (MESH:D010406), Percoll (MESH:C016039), H&amp;E (MESH:D006371), FD-4 (-), dUTP (MESH:C027078)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** S17011E
- **Cell lines:** B-1a — Homo sapiens (Human), Childhood B acute lymphoblastic leukemia, Cancer cell line (CVCL_QW66), /6 — Homo sapiens (Human), Tongue squamous cell carcinoma, Cancer cell line (CVCL_5985)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12913145/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12913145/full.md

## References

60 references — full list in the complete paper: https://tomesphere.com/paper/PMC12913145/full.md

---
Source: https://tomesphere.com/paper/PMC12913145